Michelle J Henderson Selected Research

Michelle J Henderson Research Topics

Disease

15	Neoplasms (Cancer) 02/2024 - 01/2010
9	Neuroblastoma 04/2021 - 08/2011
8	Leukemia 02/2024 - 07/2016
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2007
3	Ovarian Epithelial Carcinoma 04/2022 - 07/2014
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 08/2003
3	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2003
2	Rheumatoid Arthritis 02/2024 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2020
2	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2020 - 08/2010
2	Carcinogenesis 11/2019 - 01/2010
1	Alcoholism (Alcohol Abuse) 02/2024
1	Myeloid Leukemia (Leukemia, Myelocytic) 02/2024
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Residual Neoplasm 01/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020
1	Multiple Myeloma 01/2020
1	Wounds and Injuries (Trauma) 08/2011
1	Carcinoma (Carcinomatosis) 12/2007
1	Polyploidy 12/2007

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2003
6	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017 - 01/2010
4	Oncogene Proteins (Oncogene Protein)IBA 04/2021 - 01/2012
4	Adenosine Triphosphate (ATP)IBA 10/2020 - 08/2011
3	CBLC137IBA 01/2022 - 01/2020
2	Auranofin (Ridaura)FDA Link 02/2024 - 01/2021
2	CholesterolIBA 04/2022 - 07/2014
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 01/2021
2	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2021
2	PanobinostatIBA 01/2022 - 01/2021
2	ChromatinIBA 01/2022 - 01/2021
2	Drug CombinationsIBA 01/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2020
2	OT-82IBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2017 - 08/2003
2	multidrug resistance-associated protein 1IBA 01/2016 - 09/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016 - 09/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2010 - 12/2007
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2024
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2024
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2024
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2024
1	Disulfiram (Antabuse)FDA Link 02/2024
1	Etoposide (VP 16)FDA LinkGeneric 02/2024
1	EnzymesIBA 04/2021
1	PolyaminesIBA 04/2021
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 04/2021
1	blinatumomabIBA 01/2021
1	Nucleosomes (Nucleosome)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	RNA Helicases (RNA Helicase)IBA 01/2021
1	AntimetabolitesIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2020
1	Long Noncoding RNAIBA 11/2019
1	RNA (Ribonucleic Acid)IBA 11/2019
1	Ribosomal Proteins (Ribosomal Protein)IBA 11/2019
1	Carrier Proteins (Binding Protein)IBA 11/2019
1	N-Myc Proto-Oncogene ProteinIBA 11/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	taxaneIBA 02/2016
1	PlatinumIBA 02/2016
1	ceefourin 1IBA 09/2014
1	ceefourin 2IBA 09/2014
1	LipidsIBA 07/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2014
1	Subfamily A ATP Binding Cassette TransporterIBA 07/2014
1	Small Interfering RNA (siRNA)IBA 08/2011
1	reversanIBA 08/2011
1	Phosphotransferases (Kinase)IBA 12/2007
1	DNA (Deoxyribonucleic Acid)IBA 12/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2010
4	Drug Therapy (Chemotherapy) 02/2024 - 07/2007
1	Combined Modality Therapy 01/2021
1	Immunotherapy 01/2021
1	Transplantation 01/2021
1	Cytoreduction Surgical Procedures 02/2016
1	Remission Induction 07/2007